This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Q2 FY27 consolidated revenue Rs 274.68 crore and post-tax profit Rs 28.90 crore, versus Q2 FY26
EXCELINDUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.5 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
For the consolidated quarter ended 30 September 2026, revenue from operations was Rs 274.68 crore versus Rs 270.23 crore in the same quarter last year, while profit after tax was Rs 28.90 crore versus Rs 21.19 crore. Revenue rose 1.6% and profit 36.4%. Profit from operations before interest, tax, depreciation and amortisation was 13.3% of revenue versus 11.1%. Consolidated half-year operating cash flow was negative Rs 63.43 crore.
Profit and margin gains support the stock, but a Rs 133 crore inventory increase contributed to negative operating cash flow and may weigh on it.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹274.7 Cr | ₹270.2 Cr | +1.6% |
| Operating profit | ₹25.34 Cr | ₹20.03 Cr | +26.5% |
| Profit after tax | ₹28.90 Cr | ₹21.19 Cr | +36.4% |
| EBITDA margin | 13.3% | 11.1% | +2.2 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.